Login to Your Account



Pharma: Other News To Note


Monday, August 20, 2012
• Ranbaxy Pharmaceuticals Inc., of Princeton, N.J., said it launched an authorized generic version of pioglitazone hydrochloride tablets in the U.S. market, under an agreement with Takeda Pharmaceuticals Ltd., of Osaka, Japan.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription